| A researcher’s guide to preclinical mouse NASH models S Gallage, JEB Avila, P Ramadori, E Focaccia, M Rahbari, A Ali, ... Nature Metabolism 4 (12), 1632-1649, 2022 | 108 | 2022 |
| Sublethal necroptosis signaling promotes inflammation and liver cancer M Vucur, A Ghallab, AT Schneider, A Adili, M Cheng, M Castoldi, ... Immunity 56 (7), 1578-1595. e8, 2023 | 57 | 2023 |
| Detection of senescence using machine learning algorithms based on nuclear features I Duran, J Pombo, B Sun, S Gallage, H Kudo, D McHugh, L Bousset, ... Nature Communications 15 (1), 1041, 2024 | 30 | 2024 |
| A 5: 2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1 S Gallage, A Ali, JEB Avila, N Seymen, P Ramadori, V Joerke, L Zizmare, ... Cell Metabolism 36 (6), 1371-1393. e7, 2024 | 22 | 2024 |
| Spontaneous cholemia in C57BL/6 mice predisposes to liver cancer in NASH S Gallage, A Ali, JEB Avila, D Herebian, MM Karimi, EE Irvine, D McHugh, ... Cellular and molecular gastroenterology and hepatology 13 (3), 875-878, 2022 | 12 | 2022 |
| A researcher’s guide to preclinical mouse NASH models. Nat. Metab. 4, 1632–1649 S Gallage, JEB Avila, P Ramadori, E Focaccia, M Rahbari, A Ali, ... | 5 | 2022 |
| Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome S Gallage, EE Irvine, JE Barragan Avila, V Reen, SMA Pedroni, I Duran, ... Nature aging 4 (11), 1544-1561, 2024 | 3 | 2024 |
| Lethal lipotoxicity for liver cancer therapy S Gallage, JE Barragan Avila, M Heikenwalder Nature Cancer 2 (2), 138-140, 2021 | 1 | 2021 |
| Das Spliceosom ist ein therapeutisches Target für Ras-induzierte Seneszenz und Tumoren mit Ras-Mutation V Wagner, S Gallage, MA Ferreira, JEB Avila, M Rahbari, B Sun, A Innes, ... Zeitschrift für Gastroenterologie 61 (08), KV178, 2023 | | 2023 |
| The Role of the Macrophage MTOR-S6K Axis Effectors-S6K1 and S6K2-in NASH, NASH-HCC and Liver Fibrosis JEB Avila Ruprecht-Karls-University Heidelberg, 2023 | | 2023 |
| Beneficial effects of intermittent fasting in NASH and subsequent HCC development are executed by concerted PPAR alpha and PCK1 action in hepatocytes S Gallage, A Ali, JE Barragan Avila, N Seymen, P Ramadori, V Joerke, ... bioRxiv, 2023.10. 23.562885, 2023 | | 2023 |
| Exploring the effects of different bile acids receptor agonists in Non-Alcoholic Steatohepatitis (NASH) and NASH-related hepatocarcinogenesis E Focaccia, M Szydlowska, D Herebian, L Amann, G Monaco, L Zizmare, ... Zeitschrift für Gastroenterologie 61 (01), L3. 03, 2023 | | 2023 |
| Response to Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH Reply S Gallage, A Ali, JEB Avila, M Heikenwalder CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY 13 (5), 1590-1591, 2022 | | 2022 |
Suchira GallageGroup Leader, M3 Research Center, University of TübingenVerified email at med.uni-tuebingen.de